Allscripts Healthcare Solutions Inc. (MDRX) Social Stream



Allscripts Healthcare Solutions Inc. (MDRX): $9.40

0.14 (+1.51%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add MDRX to Watchlist
Sign Up

Industry: Medical - Services

Industry

NR

Ranked

#43 of 75

in industry

VERADIGM INC (MDRX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering VERADIGM INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 11 $22 $16 $18.555 $10.48 77.05%
2021-12-14 10 $21 $16 $18.666 $10.48 78.11%
2022-01-25 10 $22 $16 $19.222 $10.48 83.42%
2022-01-26 10 $26 $16 $19.777 $10.48 88.71%
2022-02-01 10 $26 $16 $20.111 $10.48 91.9%
2022-02-25 10 $26 $18 $20.333 $10.48 94.02%
2022-03-01 10 $26 $18 $20.666 $10.48 97.19%
2022-03-03 9 $26 $18 $20.888 $10.48 99.31%
2022-03-04 9 $27 $18 $21.666 $10.48 106.74%
2022-03-14 8 $27 $18 $22.111 $10.48 110.98%
2022-03-18 8 $27 $18 $22.444 $10.48 114.16%
2022-05-06 7 $27 $19 $23.714 $10.48 126.28%
2022-05-20 7 $27 $19 $23.285 $10.48 122.19%
2022-05-27 7 $27 $18 $22.714 $10.48 116.74%
2022-06-10 7 $27 $17 $22.428 $10.48 114.01%
2022-08-05 8 $26 $17 $21.75 $10.48 107.54%
2022-08-08 8 $26 $17 $22.142 $10.48 111.28%
2022-08-13 6 $26 $19 $23.166 $10.48 121.05%
2022-09-29 7 $26 $19 $23.166 $10.48 121.05%
2022-10-07 7 $26 $19 $22.166 $10.48 111.51%
2022-11-04 8 $26 $19 $22.166 $10.48 111.51%
2022-11-09 8 $26 $19 $22.5 $10.48 114.69%
2022-11-30 8 $26 $20 $22.833 $10.48 117.87%
2022-12-07 9 $26 $20 $23.285 $10.48 122.19%
2023-01-31 9 $26 $17 $22.5 $10.48 114.69%
2023-02-08 9 $26 $18.5 $22.687 $10.48 116.48%
2023-03-22 8 $26 $17 $21.437 $10.48 104.55%
2023-03-27 9 $26 $17 $21.437 $10.48 104.55%
2023-03-31 9 $26 $13 $20.937 $10.48 99.78%
2023-06-06 10 $26 $13 $20.055 $10.48 91.36%
2023-06-30 9 $26 $13 $19.687 $10.48 87.85%
2023-08-16 9 $26 $13 $19.687 $10.48 87.85%
2023-09-15 8 $26 $13 $19.687 $10.48 87.85%
2023-09-19 7 $26 $13 $19.214 $10.48 83.34%
2023-10-30 6 $26 $13 $19.583 $10.48 86.86%
2023-12-06 6 $26 $13 $19.2 $10.48 83.21%
2023-12-08 6 $26 $13 $17.5 $10.48 66.98%
2023-12-20 6 $26 $13 $16.75 $10.48 59.83%
2023-12-29 6 $26 $11 $16.25 $10.48 55.06%

The Trend in the Analyst Price Target


Over the past 15 months, MDRX's average price target has gone down $6.92.

MDRX reports an average of 51.51% for its upside potential over the past 50 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-06-06 10 26 13 20.062 11.95 67.88%
2023-08-16 9 26 13 19.687 13.34 47.58%
2023-10-31 6 26 13 19.200 13.19 45.56%
2023-11-21 6 26 13 19.200 12.12 58.42%
2023-11-29 6 26 13 19.200 11.70 64.1%

MDRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.33 2 0 4 0 0 6

The Trend in the Broker Recommendations


MDRX's average broker recommendation rating improved by 0.1 over the prior 46 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MDRX as an investment opportunity.

  • MDRX has a greater upside potential (average analyst target price relative to current price) than 3718.35% of all US stocks.
  • In terms of how VERADIGM INC fares relative to all US stocks, note that its average analyst price target is greater than 1234.33% of that group.
  • In terms of how VERADIGM INC fares relative to Computers stocks, note that its variance in analysts' estimates is lower than -2220.34% of that group.
  • VERADIGM INC's number of analysts covering the stock is higher than 2595.31% of stocks in the mid market cap category.

In the Computers industry, AGYS, CACI, and CRSR are the three stocks most similar to VERADIGM INC regarding the price target and analyst recommendation information presented here.

Is MDRX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!